Steven Cohen’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-200,000
Closed -$750K – 2298
2024
Q1
$750K Buy
+200,000
New +$1.17M ﹤0.01% 1532

Other funds holding PACB

Steven Cohen's PACB Position: Q3 2026 in Review

Steven Cohen increased its Pacific Biosciences (PACB) stake by 17% in Q3 2026, buying an estimated $1.13M and bringing the position to 5,590,121 shares worth $13.2M. The position accounts for 0.01% of the portfolio, ranked #1179.

Steven Cohen first reported a position in PACB in Q2 2015 and has held it in 21 quarters since. The position peaked at $88.6M in Q2 2023. 203 funds tracked by Wall St. Rank hold PACB as of Q3 2026.

  • Steven Cohen held 5,590,121 shares of Pacific Biosciences worth $13.2M as of Q3 2026.
  • Steven Cohen bought 802,821 Pacific Biosciences shares in Q3 2026, an estimated $1.13M.
  • Pacific Biosciences made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1179 holding.
  • Steven Cohen first reported a position in Pacific Biosciences in Q2 2015 and has held it in 21 quarters since.
  • Steven Cohen's Pacific Biosciences position peaked at $88.6M in Q2 2023.
  • 203 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.